Elan paid $250,000 to former director over SEC referral
Company referred publicly to Jack Schuler as a ‘disgruntled director’
Failure of Royalty Pharma bid likely to hit Elan share price, say analysts
Fate of $6.7bn offer will be decided by shareholders at extraordinary general meeting on Monday
Elan bid defence under attack from former director
Elan dismisses claims by Jack Schuler whom it calls ‘disgruntled’ as Royalty challenges Takeover Panel ruling
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices